NUTEX HEALTH ANNOUNCES CHANGE TO ITS BOARD OF DIRECTORS
Nutex Health Inc. (NASDAQ: NUTX) has announced the departure of Matthew Young, M.D. from its Board of Directors, concluding his one-year term. He will continue to lead certain facilities within the company. The board has elected Danniel Stites, M.D., a practicing emergency medicine physician with over a decade of experience, including roles as Managing Partner and Chief Medical Officer at Phoenix ER & Hospital and East Valley ER & Hospital. Stites' background and expertise are expected to support Nutex's growth in integrated healthcare delivery across its 20 micro-hospitals in 8 states. CEO Tom Vo expressed appreciation for Dr. Young's contributions and optimism about Dr. Stites' addition to the board as the company pursues its mission of patient care.
- Election of Dr. Danniel Stites to the Board, bringing over 10 years of emergency medicine experience.
- Dr. Stites' extensive background aligns with Nutex Health's focus on integrated healthcare delivery.
- Departure of Dr. Matthew Young may raise concerns regarding continuity in leadership.
"We would like to thank
"I am delighted to be joining the Board at
Headquartered in
The Hospital Division owns, develops, and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 20 facilities in 8 states.
The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our
Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Current Report on Form 10-K for the period ended
View original content:https://www.prnewswire.com/news-releases/nutex-health-announces-change-to-its-board-of-directors-301791168.html
SOURCE
FAQ
Who is the new board member for Nutex Health?
What experience does Dr. Danniel Stites bring to Nutex Health?
Why did Dr. Matthew Young leave the Board of Nutex Health?
How might Dr. Stites' election impact Nutex Health?